Icahn discloses he holds Icahn 8 Icahn 9 % stake in Mylan Laboratories , a pharmaceutical company which is in talks to buy rival King Pharmaceuticals .   October 14 , 2004    Icahn files a proxy Icahn with the SEC , claiming Mylan â€™s acquisition of King would be too expensive .   October 28 , 2004    King Pharmaceuticals announces it may have to restate its finances .   